palivizumab

Italy

Drugs containing this active substance

  • SYNAGIS

    Synagis is used to protect children at high risk of developing serious diseases caused by respiratory syncytial virus (RSV). Children at risk are those born prematurely (35 weeks or less) or those born with certain heart or lung problems.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    palivizumab -

    ATC: J06BD01

    Manufacturer: ASTRAZENECA AB